{"id":"NCT00330876","sponsor":"Kowa Research Europe","briefTitle":"Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia","officialTitle":"Open-Label, Long-Term (> 1 Year) Extension Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-06","primaryCompletion":"2007-12","completion":"2007-12","firstPosted":"2006-05-29","resultsPosted":"2010-01-18","lastUpdate":"2010-03-16"},"enrollment":545,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia","Dyslipidemias"],"interventions":[{"type":"DRUG","name":"Pitavastatin","otherNames":[]}],"arms":[{"label":"Pitavastatin 2 mg QD","type":"EXPERIMENTAL"},{"label":"Pitavastatin 4 mg QD","type":"EXPERIMENTAL"}],"summary":"This is an open-label extension study of NK-104-306 (NCT00257686) for elderly patients with hypercholesterolemia or combined dyslipidemia.","primaryOutcome":{"measure":"Change From Baseline in LDL-C","timeFrame":"Baseline to 60 weeks","effectByArm":[{"arm":"Pitavastatin 2 mg QD","deltaMin":-43.18,"sd":10.065},{"arm":"Pitavastatin 4 mg QD","deltaMin":-44.26,"sd":10.764}],"pValues":[]},"eligibility":{"minAge":"65 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":1},"locations":{"siteCount":59,"countries":["Denmark","Germany","Israel","Netherlands","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":51,"n":449},"commonTop":["Nasopharyngitis","Myalgia","Hypertension","Arthralgia","Urinary tract infection"]}}